1/8
06:15 am
cgen
Compugen (NASDAQ:CGEN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Medium
Report
Compugen (NASDAQ:CGEN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/7
07:08 am
cgen
Compugen (NASDAQ:CGEN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Compugen (NASDAQ:CGEN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
12/17
07:46 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
High
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
12/17
07:00 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Low
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
11/10
07:11 am
cgen
Compugen Reports Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
Compugen Reports Third Quarter 2025 Results [Yahoo! Finance]
11/10
07:00 am
cgen
Compugen Reports Third Quarter 2025 Results
Medium
Report
Compugen Reports Third Quarter 2025 Results
11/4
07:00 am
cgen
Compugen to Participate in Stifel 2025 Healthcare Conference
Medium
Report
Compugen to Participate in Stifel 2025 Healthcare Conference